/ Reports

Human Papillomavirus (HPV) Vaccine Market

Compare Reports on Human Papillomavirus (HPV) Vaccine Market by Price, Table of Contents, Number of pages and Publisher rating. Select any 3 reports of Human Papillomavirus (HPV) Vaccine Market to compare.

Total Results
5 Reports
Compare

Stay ahead of the game with free sample reports from top publishers across the globe!

Reports Coverage

check mark

Human Papillomavirus (HPV) Vaccine Market Key Insights

check mark

Human Papillomavirus (HPV) Vaccine Market Analysis by Regions

check mark

Human Papillomavirus (HPV) Vaccine Market Analysis by Segments

check mark

Human Papillomavirus (HPV) Vaccine Market Size (current and future)

check mark

Human Papillomavirus (HPV) Vaccine Market Competitive Benchmarking

avatar

HAVE A QUESTION?

Isabella will help you find what you are looking for.


Call: +447624248772

2 years ago

Asia Pacific Human Papillomavirus (HPV) Vaccine Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (9-valent HPV Vaccine, Quadrivalent HPV Vaccine, and Bivalent HPV Vaccine), Dosage (2 Dose and 3 Dose), Age (9 to 14 Years and 15 to 45 Years), Application (HPV-Attributable Cancer and Genital Warts), and End User (Doctors Office, Community Health Clinics, School-based Health Centers, Health Departments, Hospitals, and Others)

The APAC human papillomavirus (HPV) vaccine market is expected to grow from US$ 567.57 million in 2022 to US$ 826.34 million by 2028; it is estimated to grow at a CAGR of 6.5% from 2022 to 2028.

 

Companies are undertaking many research and development activities to introduce advanced HPV tests. For instance, in May 2021, BD, a leading medical technology company, launched the f...

Delivery Time

1 business day

2 years ago

"Europe Human Papillomavirus (HPV) Vaccine Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (9-valent HPV Vaccine, Quadrivalent HPV Vaccine, and Bivalent HPV Vaccine), Dosage (2 Dose and 3 Dose), Age (9 to 14 Years and 15 to 45 Years), Application (HPV-Attributable Cancer and Genital Warts), and End User (Doctors Office, Community Health Clinics, School-based Health Centers, Health Departments, Hospitals, and Others)

The Europe human papillomavirus (HPV) vaccine market is expected to grow from US$ 1,202.66 million in 2022 to US$ 1,598.81 million by 2028; it is estimated to grow at a CAGR of 4.9% from 2022 to 2028.

 

Human papillomavirus (HPV) is a common sexually transmitted infection and can cause cervical, oropharyngeal cancer, and cancer of the vagina, vulva, penis, or anus. It also caus...

Delivery Time

1 business day

2 years ago

"Middle East & Africa Human Papillomavirus (HPV) Vaccine Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (9-valent HPV Vaccine, Quadrivalent HPV Vaccine, and Bivalent HPV Vaccine), Dosage (2 Dose and 3 Dose), Age (9 to 14 Years and 15 to 45 Years), Application (HPV-Attributable Cancer and Genital Warts), and End User (Doctors Office, Community Health Clinics, School-based Health Centers, Health Departments, Hospitals, and Others)

The MEA human papillomavirus (HPV) vaccine market is expected to grow from US$ 82.91 million in 2022 to US$ 100.86 million by 2028; it is estimated to grow at a CAGR of 3.3% from 2022 to 2028.

 

Healthcare organizations have developed and adopted several strategies to prevent and eliminate HPV infections. The World Health Assembly, in August 2020, adopted the strategy for cervi...

Delivery Time

1 business day

2 years ago

"North America Human Papillomavirus (HPV) Vaccine Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (9-Valent HPV Vaccine, Quadrivalent HPV Vaccine, and Bivalent HPV Vaccine), Dosage (2 Dose and 3 Dose), Age (9 to 14 Years and 15 to 45 Years), Application (HPV-Attributable Cancer and Genital Warts), and End User (Doctors Office, Community Health Clinics, School-Based Health Centers, Health Departments, Hospitals, and Others)

The North America human papillomavirus (HPV) vaccine market is expected to grow from US$ 2,247.18 million in 2022 to US$ 2,964.96 million by 2028; it is estimated to grow at a CAGR of 4.7% from 2022 to 2028.

 

The increase in programs for HPV awareness is one of the effective strategies to increase vaccination uptake and eliminate HPV-associated cancers. Dana-Farber Cancer Inst...

Delivery Time

1 business day

2 years ago

"South America Human Papillomavirus (HPV) Vaccine Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (9-valent HPV Vaccine, Quadrivalent HPV Vaccine, and Bivalent HPV Vaccine), Dosage (2 Dose and 3 Dose), Age (9 to 14 Years and 15 to 45 Years), Application (HPV-Attributable Cancer and Genital Warts), and End User (Doctors Office, Community Health Clinics, School-Based Health Centers, Health Departments, Hospitals, and Others)

The South America human papillomavirus (HPV) vaccine market is expected to grow from US$ 173.52 million in 2022 to US$ 239.53 million by 2028; it is estimated to grow at a CAGR of 5.5% from 2022 to 2028.

 

Companies are undertaking many research and development activities to introduce advanced HPV tests. For instance, in May 2021, BD, a leading medical technology company, launc...

Delivery Time

1 business day

Human Papillomavirus (HPV) Vaccine Market

The human papillomavirus (HPV) is a sexually transmitted virus that can cause various types of cancer, including cancer of the cervix, anus, and throat. The HPV vaccine is a vaccine that protects against infection with certain types of HPV. It is usually given to adolescents and young adults to prevent HPV-related cancers and other diseases.


The HPV vaccine market is a growing one, with a number of different vaccines available. The global HPV vaccine market size was valued at $XX billion in 2019 and is expected to reach $XX billion by 2031, at a CAGR of **% during the forecast period.


There are a number of factors driving the growth of the HPV vaccine market, including increasing awareness of the importance of vaccination, the rising incidence of HPV-related cancers, and the availability of new and improved vaccines.


Some of the key players in the HPV vaccine market include GlaxoSmithKline plc; Inovio Pharmaceuticals; Merck & Co., Inc.; R-Pharm; Sanofi; and Serum Institute of India Pvt. Ltd. These companies offer a variety of HPV vaccines.


Some of the latest trends in the HPV vaccine market include the development of new vaccines that protect against a wider range of HPV types, the use of adjuvants to improve the effectiveness of vaccines, and the use of novel delivery systems to improve vaccination rates. Overall, the HPV vaccine market is expected to continue growing in the coming years as more people become aware of the importance of vaccination and the availability of new and improved vaccines increases.

Frequently Asked Questions

Can i create custom Project on Human Papillomavirus (HPV) Vaccine Market?

Yes you can create custom project on Human Papillomavirus (HPV) Vaccine Market based on your budget and scope.

How to Compare Table of Contents of Human Papillomavirus (HPV) Vaccine Market Reports?

You can select three reports on Human Papillomavirus (HPV) Vaccine Market to compare Table of Contents.

How to compare reports on Human Papillomavirus (HPV) Vaccine Market?

You can easily select multiple reports on Human Papillomavirus (HPV) Vaccine Market published by different publishers.

Continue Reading

Drake and His Customized T-Shirt Tribute to Sidhu Moosewala

Drake wore a customized t-shirt to his concert with the late Sidhu Moosewala’s face on it. Read on as we tell you more.

Procurement Outsourcing: What It Is, How It Works And Why You Need To Start Thinking Ab...

Although procurement outsourcing is a failry new industry, it has shown to offer several benefits to businesses. Keep reading to learn more

False Botulinum Toxin Product Causing Stir

Dysport and Botulinum Toxin, commonly known as Botox, are used for similar purposes in the medical industry. Dysport is used for removing glabellar lines and light wrinkles, and has also been FDA-approved for lower limb spasticity and cervical dystonia. Both the substances are introduced into the body through intramuscular injections, and care must be taken by the clinic in question to ensure sterile conditions for injecting each substance.

Recent Press Releases

Douglas Insights Adds Computer-Assisted Coding Market Research Reports to Its Compariso...

Douglas Insights Comparison Engine has diversified its reserve of public and private market research reports with the introduction of computer-assisted codin...

Douglas Insights Adds Hair Care Appliances Market Research Reports to Its Comparison En...

Douglas Insights, the world's first-ever comparison engine for market research reports, has added Hair Care Appliances Market Research Reports to its da...

Douglas Insights Adds Optical Wireless Communication Market Research Reports to Its Com...

Douglas Insights has included Optical Wireless Communication Market in its comparison engine to enable industry experts and businesses to analyze past and cu...